NMDA Receptor Antagonists Disinhibit Rat Posterior Cingulate and Retrosplenial Cortices: a Potential Mechanism of Neurotoxicity

Overview

Journal J Neurosci

Specialty Neurology

Date 2002 Apr 12

PMID 11943810

Citations 47

Authors

Qiang Li

Suzanne Clark

Darrell V Lewis

Wilkie A Wilson

Affiliations

Soon will be listed here.

Abstract

NMDA receptor antagonists produce region-specific neurodegeneration by an undetermined mechanism, but one proposed mechanism involves disinhibition. In certain areas of the brain, NMDA receptors mediate excitatory drive onto inhibitory interneurons. Thus, NMDA receptor/channel antagonists may reduce inhibition (i.e., produce "disinhibition"). If a sufficient level of disinhibition is produced, enhanced vulnerability to excitotoxicity may result. Furthermore, if there are region-specific differences in NMDA antagonist-induced disinhibition, this could underlie region-specific NMDA antagonist-induced neurotoxicity. In the present study, we tested this hypothesis by exposing rat brain slices to the NMDA receptor antagonist dizocilpine maleate (MK-801) and measuring MK-801-induced disinhibition in areas of higher and lower vulnerability to neurodegeneration [posterior cingulate/retrosplenial cortices (PCC/RSC) and parietal cortex, respectively]. Using whole-cell patch-clamp techniques, bicuculline-sensitive GABA(A) receptor-mediated IPSCs were measured in biocytin-labeled pyramidal neurons in the PCC/RSC and parietal cortex. In the PCC/RSC, bath-applied MK-801 (10-40 microm) produced disinhibition, shown as a concentration-dependent decrease in spontaneous IPSC frequency and amplitude; MK-801 (40 microm) also reduced evoked IPSC amplitudes. In parietal cortex, MK-801 produced significantly less disinhibition. To determine whether disinhibition is caused by presynaptic or postsynaptic mechanisms, we tested the effects of MK-801 (40 microm) against miniature IPSC (mIPSC) frequency and amplitude in tetrodotoxin (TTX; 0.5 microm)-treated slices and found that MK-801 did not alter mIPSC frequency or amplitude. Taken together, these results suggest that NMDA receptors regulate activity of inhibitory interneurons and, consequently, GABA release in certain cortical areas. This region-specific reduction in inhibitory input to pyramidal cells could underlie the region-specific neurotoxicity of NMDA antagonists.

Citing Articles

Unique Transcriptomic Cell Types of the Granular Retrosplenial Cortex are Preserved Across Mice and Rats Despite Dramatic Changes in Key Marker Genes.

Brooks I, Jedrasiak-Cape I, Rybicki-Kler C, Ekins T, Ahmed O bioRxiv. 2024; .

PMID: 39345493 PMC: 11429737. DOI: 10.1101/2024.09.17.613545.

mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex.

LaCrosse A, May C, Griffin W, Olive M Neuroscience. 2024; 555:83-91.

PMID: 39019391 PMC: 11344657. DOI: 10.1016/j.neuroscience.2024.06.016.

Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions.

Iorgu A, Vasilescu A, Pfeiffer N, Spanagel R, Mallien A, Inta D Eur Arch Psychiatry Clin Neurosci. 2023; 274(4):1013-1019.

PMID: 37934233 PMC: 11127870. DOI: 10.1007/s00406-023-01699-3.

Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.

Vinnakota C, Hudson M, Jones N, Sundram S, Hill R Int J Mol Sci. 2023; 24(14).

PMID: 37511595 PMC: 10380280. DOI: 10.3390/ijms241411835.

Regional contributions of D-serine to Alzheimer's disease pathology in male mice.

Ni X, Inoue R, Wu Y, Yoshida T, Yaku K, Nakagawa T Front Aging Neurosci. 2023; 15:1211067.

PMID: 37455930 PMC: 10339350. DOI: 10.3389/fnagi.2023.1211067.

References

McDonald J, Silverstein F, Johnston M . MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience. 1990; 38(1):103-13. DOI: 10.1016/0306-4522(90)90377-g. View

Ellison G . The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev. 1995; 20(2):250-67. DOI: 10.1016/0165-0173(94)00014-g. View

Grunze H, Rainnie D, Hasselmo M, Barkai E, Hearn E, McCarley R . NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci. 1996; 16(6):2034-43. PMC: 6578507. View

FOSTER A, Gill R, Woodruff G . Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J Neurosci. 1988; 8(12):4745-54. PMC: 6569557. View

Mott D, Li Q, Okazaki M, Turner D, Lewis D . GABAB-Receptor-mediated currents in interneurons of the dentate-hilus border. J Neurophysiol. 1999; 82(3):1438-50. DOI: 10.1152/jn.1999.82.3.1438. View

Dirnagl U, Tanabe J, Pulsinelli W . Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat. Brain Res. 1990; 527(1):62-8. DOI: 10.1016/0006-8993(90)91060-t. View

Sharp F, Butman M, Aardalen K, Nickolenko J, Nakki R, Massa S . Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. Psychopharmacol Bull. 1994; 30(4):555-60. View

Sveinbjornsdottir S, Sander J, Upton D, Thompson P, Patsalos P, Hirt D . The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 1993; 16(2):165-74. DOI: 10.1016/0920-1211(93)90031-2. View

Brennan P, Keverne E . Impairment of olfactory memory by local infusions of non-selective excitatory amino acid receptor antagonists into the accessory olfactory bulb. Neuroscience. 1989; 33(3):463-8. DOI: 10.1016/0306-4522(89)90398-9. View

10.

Zhou F, Hablitz J . AMPA receptor-mediated EPSCs in rat neocortical layer II/III interneurons have rapid kinetics. Brain Res. 1998; 780(1):166-9. DOI: 10.1016/s0006-8993(97)01311-5. View

11.

Tomitaka S, Tomitaka M, Tolliver B, Sharp F . Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex. Eur J Neurosci. 2000; 12(4):1420-30. DOI: 10.1046/j.1460-9568.2000.00018.x. View

12.

Wieloch T . Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science. 1985; 230(4726):681-3. DOI: 10.1126/science.2996146. View

13.

Kim H, Connors B . Apical dendrites of the neocortex: correlation between sodium- and calcium-dependent spiking and pyramidal cell morphology. J Neurosci. 1993; 13(12):5301-11. PMC: 6576423. View

14.

Rod M, Auer R . Pre- and post-ischemic administration of dizocilpine (MK-801) reduces cerebral necrosis in the rat. Can J Neurol Sci. 1989; 16(3):340-4. DOI: 10.1017/s031716710002919x. View

15.

Loscher W, Honack D . The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors. J Pharmacol Exp Ther. 1991; 257(3):1146-53. View

16.

Kawaguchi Y . Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex. J Neurosci. 1995; 15(4):2638-55. PMC: 6577784. View

17.

Lubke J, Markram H, Frotscher M, Sakmann B . Frequency and dendritic distribution of autapses established by layer 5 pyramidal neurons in the developing rat neocortex: comparison with synaptic innervation of adjacent neurons of the same class. J Neurosci. 1996; 16(10):3209-18. PMC: 6579140. View

18.

Salin P, Prince D . Spontaneous GABAA receptor-mediated inhibitory currents in adult rat somatosensory cortex. J Neurophysiol. 1996; 75(4):1573-88. DOI: 10.1152/jn.1996.75.4.1573. View

19.

HESTRIN S . Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature. 1992; 357(6380):686-9. DOI: 10.1038/357686a0. View

20.

Cohen G, Doze V, Madison D . Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron. 1992; 9(2):325-35. DOI: 10.1016/0896-6273(92)90171-9. View